Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04134936
Brief Title: Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL

First Submitted : October 11, 2019
First Submitted that Met QC Criteria : October 21, 2019
First Posted : October 22, 2019

Last Update Submitted that Met QC Criteria : October 12, 2020
Last Update Posted : October 14, 2020